Bracco Imaging

Bracco is an international group active in the healthcare sector and a leader in the diagnostic imaging field. With approximately 3,600 employees and an annual total revenue of about 1.5 billion euros, 87% of which comes from international sales. In the field of research and development, the company invests approximately 10% of its reference turnover in the imaging diagnostics and medical devices sectors. The group's main products are contrast agents and medical substances used to enhance the accuracy of biomedical imaging diagnostics and care for patients affected by various types and severities of diseases. Bracco offers a wide and innovative portfolio of products and solutions, complemented by several medical devices and advanced contrast imaging product management systems developed by its American company ACIST for cardiology and radiology, covering all diagnostic modalities. Since its establishment, Bracco has been a socially responsible company in all areas, whether in business or otherwise. Its subsidiary, Bracco Imaging, is one of the global leading companies in the diagnostic imaging field, which includes X-ray imaging (including Computed Tomography - CT), Magnetic Resonance Imaging (MRI), contrast-enhanced ultrasound, and nuclear medicine.